Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$46,525
+$2,085 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#212
of 282 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $236,684 across 3 Biotechnology names. BNTX ranks #2 (19.7% of the industry book) .
All Filings in BNTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,525 | 500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $44,440 | 500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $47,600 | 500 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $49,310 | 500 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $53,235 | 500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $45,530 | 500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $56,975 | 500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $59,385 | 500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $40,180 | 500 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $46,125 | 500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $116,094 | 1,100 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $119,504 | 1,100 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $118,723 | 1,100 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $137,027 | 1,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $165,242 | 1,100 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $148,368 | 1,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $164,010 | 1,100 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $187,616 | 1,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $283,580 | 1,100 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||